Other languages Cipher Pharmaceuticals Inc.

Equities

CPH

CA17253X1050

Market Closed - Toronto S.E. Other stock markets 03:59:47 2024-04-26 pm EDT			5-day change	1st Jan Change
8.5 ^CAD	0.00%		0.00%	+53.43%

Mar. 15	Transcript : Cipher Pharmaceuticals Inc., Q4 2023 Earnings Call, Mar 15, 2024
Mar. 14	Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cipher Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 14
Cipher Pharmaceuticals Q4 Profit Falls 61% on Charges	Mar. 14
Cipher Pharmaceuticals Inc. announces an Equity Buyback for 1,337,195 shares, representing 5.57% of its issued share capital.	Nov. 15
Cipher Pharmaceuticals Inc. authorizes a Buyback Plan.	Nov. 14
Cipher Pharmaceuticals Seeks Acquisitions	Nov. 10
Cipher Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Cipher Pharmaceuticals Announced Final Results of Substantial Issuer Bid	23-10-12
Cipher Pharmaceuticals Inc. announces an Equity Buyback for CAD 6 million worth of its shares.	23-09-05
Cipher Pharmaceuticals Inc.authorizes a Buyback Plan.	23-09-04
Cipher Pharmaceuticals Seeks M&A	23-08-11
Cipher Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Cipher Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11
Cipher Pharmaceuticals Fourth-Quarter Profit Rises Even as Revenue Weakens by 17%	23-03-16
Cipher Pharmaceuticals Inc. Declares Quarterly Dividend, Payable on or About February 28, 2023	23-02-13
Cipher Pharmaceuticals to Seek Acquisitions	22-11-11
Cipher Pharmaceuticals Reports Strong Third Quarter Results, Highlighted by US$1.09 in Cash Per Share	22-11-11
Cipher Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10
Cipher Pharmaceuticals Inc. announces an Equity Buyback for 1,403,293 shares, representing 5.59% of its issued share capital.	22-09-19
Cipher Pharmaceuticals Inc. authorizes a Buyback Plan.	22-09-18
Cipher Pharmaceuticals Reports Q2 Diluted EPS of US$0.08	22-08-11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Cipher Pharmaceuticals Inc.

Equities

CPH

CA17253X1050

Other languages

Filters